Financial Performance Summary - For the first quarter of fiscal year 2026, the company reported revenue of $30.4 million, a decrease of 22.8% compared to $39.3 million in the same period of fiscal year 2025 [1][3][4] - Gross profit was $5.1 million, down from $7.7 million year-over-year, resulting in a gross margin of 17.0%, compared to 19.5% in the prior year [1][4] - Total operating expenses decreased significantly to $7.8 million from $12.9 million in the previous year, marking a reduction of nearly 39% [2][3] - The net loss for the quarter was $3.3 million, or $0.06 per share, an improvement from a net loss of $5.6 million, or $0.10 per share, in the same quarter last year [1][4][17] Strategic Initiatives - The company has adopted a quality-over-quantity strategy, which has led to a significant reduction in operating expenses and improved financial metrics [2][3] - The company is focusing on high-quality customer selection, which has contributed to a decrease in net accounts receivable from $62.4 million to $44.5 million, a decline of approximately 29% [2][3] - The joint venture IKE Tech is making substantial progress globally, working with regulators in Europe, Southeast Asia, and the Middle East to establish age-gating technology as a mandatory standard [3] Future Outlook - The company anticipates that the positive trends in financial performance will continue throughout fiscal year 2026 [2] - There are ongoing discussions with several large and medium-sized tobacco companies regarding the innovative G-Mesh technology solutions for next-generation electronic vapor devices, with potential licensing or partnership agreements expected in the coming months [3]

Core Viewpoint - Ispire Technology Inc. announced its financial performance for the fiscal year ending June 30, 2025, highlighting a strategic shift from the CBD vaporizer industry to the higher-value nicotine sector, which is expected to enhance long-term sustainable growth despite a decline in revenue and an increase in net loss [2][3][4]. Financial Performance Summary - Revenue for the fiscal year 2025 reached $127.5 million, down from $151.9 million in fiscal year 2024, primarily due to the strategic shift in focus [2][3]. - Gross profit was $22.6 million, compared to $29.8 million in the previous fiscal year, with a gross margin of 17.8%, down from 19.6% [2][3]. - Total operating expenses increased to $60.5 million from $43.7 million in the prior year, driven by higher sales and marketing expenses and increased bad debt provisions [2][3]. - The net loss for fiscal year 2025 was $39.2 million, or $0.69 per share, compared to a net loss of $14.8 million, or $0.27 per share, in fiscal year 2024 [4][14]. Strategic Initiatives - The company is focusing on a "quality first" strategy, aiming to strengthen long-term partnerships and ensure sustainable growth [2]. - Ispire is investing in breakthrough technologies, including age verification technology from IKE Tech LLC and proprietary G-Mesh technology, which are gaining attention from major global tobacco companies [2]. - The company is actively preparing for PMTA submissions for flavored ENDS products, which will incorporate IKE Tech's age verification technology [2][3]. Operational Adjustments - The company has streamlined operations and implemented cost control measures, expecting to save approximately $10.2 million in annual salary costs [2]. - Administrative expenses decreased from $31.1 million in fiscal year 2024 to $30 million in fiscal year 2025 [2].

Company Overview - Ispire Technology Inc. is an innovator in the development and commercialization of vaporization technology and precise dosing [1][2] - The company has over 200 patents for inventions/designs, either owned or licensed from affiliates, and sells products under the Aspire brand globally [2] Financial Performance - Ispire Technology Inc. will hold a performance conference call on May 12, 2025, to discuss its financial results for the third quarter of the fiscal year ending March 31, 2025 [1] Market Presence - The company's vaporization products are primarily sold through an ODM model under the Ispire brand to other vaporization companies [2] - Ispire Technology has recently initiated marketing activities in Canada and Europe, expanding its sales efforts beyond the United States [2]